Abstract
In this issue of Blood, Tili et al identify an important link between microRNAs and the metabolic adaptation characteristic of cancer cells.1 In chronic lymphocytic leukemia (CLL), the microRNA, miR-125b becomes down-regulated resulting in an increase in the expression and activity of a myriad of metabolic enzymes that promote metabolic reprogramming in a way that favors malignant transformation.

This publication has 7 references indexed in Scilit: